Neuromyelitis optica spectrum disorder (NMOSD) is a rare autoimmune condition in which the body's own defenses turn against ...
Mental health professionals at Kaiser are raising concerns about an artificial intelligence tool that records medical appointments, saying it should have more safeguards.
GlobalData on MSN
First patient dosed in Deciphera’s Phase III INTREPID study
The trial is enrolling in the US and will include regions in the Asia Pacific, Europe, Latin America, and North America.
The new-age pharmaceutical landscape shows a growing reliance on customized, specialized therapies known to customers as compounded medicines. Compounding occurs when an approved and licensed ...
Once hailed as the “gold standard” for cancer management, though, MDTs are now under strain. Over the years, the number of referrals have gone up drastically and meeting times have increased to up to ...
Researchers at Tel Aviv University's Gray Faculty of Medical and Health Sciences have uncovered how a natural and essential ...
Compounded drugs sold for cash prices don’t generate billing records that would allow regulators to track basic information, ...
A single-center observational cohort (n=116; 81% RRMS) receiving ocrelizumab from 2018–2023 enabled longitudinal tracking of IgG, IgA, and IgM across treatment cycles. Serial dosing produced gradual ...
5don MSN
Medicare will start covering obesity drugs for the first time. Here's what patients should know
The move could unlock millions of new patients for Novo Nordisk and Eli Lilly and expand access to medications that were ...
I repeat myself when I say that healthcare workers truly deserve the world. Not only do they save lives, but they're often ...
Phase 3 clinical trial will evaluate aglatimagene besadenovec plus valacyclovir in combination with continued pembrolizumab versus standard-of-care docetaxel chemotherapy in patie ...
Blood-based T‑cell receptor sequencing reveals immune “fingerprints” in Lynch syndrome, helping track precancers early and paving the way for new cancer surveillance biomarkers. For Eduardo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results